Change search criteria ↓

Search results

12 projects found matching your search criteria:

  1. 1. Identification of epigenetic mechanisms contributing to glioma drug resistance

    Principal investigator: dr Jakub Karol Mieczkowski

    Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

    Call: POLONEZ 3, Panel: NZ2

  2. 2. Molecular mechanism of epigenetic drugs action to prevent multi-organ injury in a mouse model of sepsis

    Principal investigator: dr Michał Marek Mikula

    Centrum Onkologii - Instytut im. Marii Skłodowskiej-Curie

    Call: HARMONIA 6, Panel: NZ5

  3. 3. Drug metabolizing enzymes (DMEs) in liver pathology, proteomic characteristics, transcriptional and epigenetic regulatio…

    Principal investigator: prof. Marek Droździk

    Pomorski Uniwersytet Medyczny w Szczecinie

    Call: OPUS 19, Panel: NZ7

  4. 4. Proteomic characterization, transcriptional and epigenetic regulation of drugtransporters in colorectal cancer

    Principal investigator: Nina Ewa Komaniecka

    Pomorski Uniwersytet Medyczny w Szczecinie

    Call: PRELUDIUM 24, Panel: NZ7

  5. 5. Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet…

    Principal investigator: dr hab. Agnieszka Wnuk

    Instytut Farmakologii PAN

    Call: OPUS 26, Panel: NZ7

  6. 6. Deciphering the Chemoproteomics and Chemotranscriptomics of Anti-Alzheimer Drugs for Novel Druggable Target Identificati…

    Principal investigator: prof. Krzysztof Sobczak

    Uniwersytet im. Adama Mickiewicza w Poznaniu, Wydział Biologii

    Call: JPND Call 2023, Panel: NZ5

  7. 7. Identification of new, clinically relevant genetic and epigenetic aberrations by next-generation sequencing in chronic m…

    Principal investigator: dr Tomasz Artur Stokłosa

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

    Call: HARMONIA 6, Panel: NZ5

  8. 8. The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

    Principal investigator: dr Michał Jerzy Woźniak

    Uniwersytet Medyczny w Łodzi

    Call: OPUS 28, Panel: NZ7

  9. 9. M6A RNA methylation signatures as a targets for HPV-dependent HNSCC therapy

    Principal investigator: Kamila Ostrowska

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu

    Call: OPUS 27, Panel: NZ5

  10. 10. Structure-guided design of histone demethylase inhibitors for cancer therapy.

    Principal investigator: dr Piotr Henryk Małecki

    Instytut Chemii Bioorganicznej PAN

    Call: SONATA 17, Panel: NZ7

  11. 11. Searching for behavioural and molecular predictors of long-term benzodiazepine administration in preclinical chronic str…

    Principal investigator: dr Karolina Anna Kołosowska

    Instytut Psychiatrii i Neurologii

    Call: SONATINA 2, Panel: NZ7

  12. 12. The role of DNA methylation in enhancing the sensitivity of colorectal cancer cells to topoisomerase inhibitors.

    Principal investigator: Alicja Patrycja Pawlak

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

    Call: PRELUDIUM 9, Panel: NZ3

Graphic design and implementation: Jakub Piotrowski